Salim S. Abdool Karim

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.

Karim F, Riou C, Bernstein M, Jule Z, Lustig G, van Graan S, Keeton RS, Upton JL, Ganga Y, Khan K, Reedoy K, Mazibuko M, Govender K, Thambu K, Ngcobo N, Venter E, Makhado Z, Hanekom W, von Gottberg A, Hoque M, Karim QA, Abdool Karim SS, Manickchund N, Magula N, Gosnell BI, Lessells RJ, Moore PL, Burgers WA, de Oliveira T, Moosa MS, Sigal A.

Nat Commun. 2024 Mar 15. 15(1):2360. PMID: 38491050

SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations.

Lustig G, Ganga Y, Rodel HE, Tegally H, Khairallah A, Jackson L, Cele S, Khan K, Jule Z, Reedoy K, Karim F, Bernstein M, Ndung'u T, Moosa MS, Archary D, de Oliveira T, Lessells R, Neher RA, Abdool Karim SS, Sigal A.

Virus Evol. 2024. 10(1):vead075. PMID: 38361824

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.

Khan K, Lustig G, Römer C, Reedoy K, Jule Z, Karim F, Ganga Y, Bernstein M, Baig Z, Jackson L, Mahlangu B, Mnguni A, Nzimande A, Stock N, Kekana D, Ntozini B, van Deventer C, Marshall T, Manickchund N, Gosnell BI, Lessells RJ, Karim QA, Abdool Karim SS, Moosa MS, de Oliveira T, von Gottberg A, Wolter N, Neher RA, Sigal A.

Nat Commun. 2023 Dec 06. 14(1):8078. PMID: 38057313

Infectious diseases and the Sustainable Development Goals: progress, challenges and future directions.

Abdool Karim Q, Abdool Karim SS.

Nat Rev Microbiol. 2023 10. 21(10):626-627. PMID: 37463990

Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization.

Abdool Karim SS, Barre-Sinoussi F, Varmus HE, Serwadda D, Bukusi E, M'boup S, Kamarulzaman A, Swaminathan S, Pape JW.

N Engl J Med. 2023 Sep 28. 389(13):1159-1161. PMID: 37694893

Threatening the Future of Global Health - NIH Policy Changes on International Research Collaborations.

Ko AI, Abdool Karim SS, Morel C, Swaminathan S, Daszak P, Keusch GT.

N Engl J Med. 2023 09 07. 389(10):869-871. PMID: 37668223

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial.

Mahomed S, Garrett N, Potloane D, Sikazwe IT, Capparelli E, Harkoo I, Gengiah TN, Zuma NY, Osman F, Mansoor L, Archary D, Myeni N, Radebe P, Samsunder N, Doria-Rose N, Carlton K, Gama L, Koup RA, Narpala S, Serebryannyy L, Moore P, Williamson C, Pozzetto B, Hankins C, Morris L, Karim QA, Abdool Karim S.

BMJ Open. 2023 08 28. 13(8):e076843. PMID: 37640457

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb.

Naicker N, Rodel H, Perumal R, Ganga Y, Bernstein M, Benede N, Abdool Karim S, Padayacthi N, Sigal A, Naidoo K.

Infect Drug Resist. 2023. 16:3629-3638. PMID: 37309381

Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa.

Samsunder N, Lustig G, de Vos M, Ngcapu S, Giandhari J, Tshiabuila D, San EJ, Lewis L, Kharsany AB, Cawood C, de Oliveira T, Abdool Karim Q, Abdool Karim S, Escadafal C, Naidoo K, Sivro A.

J Clin Virol. 2023 08. 165:105498. PMID: 37329842

Vaccine access, equity and justice: COVID-19 vaccines and vaccination.

Privor-Dumm L, Excler JL, Gilbert S, Abdool Karim SS, Hotez PJ, Thompson D, Kim JH.

BMJ Glob Health. 2023 06. 8(6). PMID: 37290896